EML4 and non-small cell lung carcinoma: Although favorable clinical outcomes have been achieved with PEM treatment in EML4-ALK rearrangement NSCLC, it is still necessary to address the underlying mechanism of PEM in the EML4-ALK rearrangement NSCLC.